13G Filing: Armistice Capital and Novelion Therapeutics Inc. (NVLN)

Page 10 of 10

Page 10 of 10 – SEC Filing

Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13G dated May 23, 2017 relating to the Common Stock of Novelion Therapeutics Inc. shall be filed on behalf of the undersigned.
Armistice Capital, LLC*
By:
/s/ Steven Boyd
Steven Boyd
Managing Member
Armistice Capital Master Fund Ltd.
By:
/s/ Steven Boyd
Steven Boyd
Director
By:
/s/  Steven Boyd*
Steven Boyd

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)

Page 10 of 10